SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-049909
Filing Date
2021-04-13
Accepted
2021-04-13 21:58:44
Documents
1
Period of Report
2021-04-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2112857-1_3seq.html 3  
1 OWNERSHIP DOCUMENT tm2112857-1_3seq.xml 3 1524
  Complete submission text file 0001104659-21-049909.txt   2975
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Issuer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 RADNOR CORPORATE CENTER STE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address
Pfanstiel Steven (Reporting) CIK: 0001856059 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36576 | Film No.: 21824430